Breaking News Instant updates and real-time market news.

DLTH

Duluth Holdings

$19.56

0.41 (2.14%)

, PG

Procter & Gamble

$76.48

-0.76 (-0.98%)

08:50
06/14/18
06/14
08:50
06/14/18
08:50

DA Davidson to hold a conference

Brands, Channels & the Changing Consumer Conference will be held in Chicago on June 14.

DLTH

Duluth Holdings

$19.56

0.41 (2.14%)

PG

Procter & Gamble

$76.48

-0.76 (-0.98%)

OXM

Oxford Industries

$88.16

-4.31 (-4.66%)

  • 14

    Jun

  • 26

    Jun

DLTH Duluth Holdings
$19.56

0.41 (2.14%)

08/23/17
08/23/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ultragenyx (RARE) downgraded to Hold from Buy at SunTrust, with analyst Edward Nash slashing his price target to $55 from $105 after the company reported negative topline data from the Phase III trial for Ace-ER for GNE myopathy. Nash is disappointed by this first major clinical setback for the company and removed Ace-ER from his valuation models. 2. Duluth Holdings (DLTH) downgraded to Market Perform from Outperform at Raymond James, with analyst Dan Wewer citing increasing industry challenges. Wewer is concerned about increasing promotional activity and aggressive pricing tactics by competitors. 3. Cree (CREE) downgraded to Underweight from Equal Weight at Stephens. 4. Washington Prime (WPG) downgraded to Underperform from Neutral at Boenning & Scattergood by analyst Floris van Dijkum due to a more expensive NAV relative valuation caused by the more than 6% sector outperformance in the current quarter. 5. Baozun (BZUN) downgraded to Hold from Buy at Deutsche Bank by analyst Eileen Deng citing valuation after the stock's 18% rise in the past six months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/17
BMOC
11/01/17
DOWNGRADE
BMOC
Market Perform
Duluth Holdings downgraded to Market Perform from Outperform at BMO Capital
11/01/17
BMOC
11/01/17
DOWNGRADE
Target $20
BMOC
Market Perform
Duluth Holdings cut to Market Perform at BMO Capital on competitive pressure
As previously noted, BMO Capital analyst John Morris downgraded Duluth Holdings to Market Perform from Outperform and cut his price target to $20 from $30. Morris notes that Duluth peers are offering more promotions, which could pressure the company's earnings into the second half. The analyst also says the unseasonably warm fall weather and California wildfires may impact Q3 results, with risk that the management's Q4 outlook may turn more cautious.
11/27/17
DADA
11/27/17
NO CHANGE
Target $25
DADA
Buy
Duluth Holdings to benefit from store growth visibility, says DA Davidson
DA Davidson analyst Andrew Burns preview's Thursday's Q3 earnings for Duluth Holdings, saying he is positive on the company's omni-channel positioning, high visibility to store growth, and potential earnings acceleration. While the overall retail environment remains difficult, the analyst writes in his research report, the company has had a better assortment of seasonal products while also lapping the warmer temperatures going into the winter last year. Burns keeps his Buy rating and $25 price target on Duluth.
PG Procter & Gamble
$76.48

-0.76 (-0.98%)

04/20/18
04/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Deutsche Bank aw well as Argus. 2. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman Sachs and to Underperform from Neutral at BofA/Merrill. 3. DHT Holdings (DHT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette saying he has become more constructive on a crude tanker recovery in 2019 but cites relative valuation for the downgrade on DHT. 4. Skechers (SKX) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing the company's first quarter results. 5. Tyson Foods (TSN) downgraded to Hold from Buy at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/18
MSCO
06/11/18
NO CHANGE
Target $80
MSCO
Equal Weight
P&G fundamentals weak despite sum-of-the-parts upside, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian updated his sum-of-the-parts analysis for Procter & Gamble following numerous questions from investors, arriving at a SOTP enterprise value including corporate expense of $84 per share based on his 2019 estimates. Despite the SOTP upside, he keeps an Equal Weight rating on P&G shares, given secularly weak home and personal care industry trends in the U.S. and the company's skew to high priced products in developed markets.
06/08/18
BERN
06/08/18
NO CHANGE
Target $91
BERN
Outperform
P&G sum-of-the-parts analysis suggests 30% upside in break-up, says Bernstein
Bernstein analyst Ali Dibadj said that although "no SOTP analysis is perfect," his own sum-of-the-parts analysis of Procter & Gamble suggests over 30% upside from current levels in a break-up scenario. The analyst, who has long argued that a break-up offers P&G a chance to "jolt culture, reset bureaucracies, rethink processes, accelerate decision-making, align accountabilities, and reduce costs," keeps an Outperform rating and $91 price target on P&G shares.
04/20/18
ARGS
04/20/18
DOWNGRADE
ARGS
Hold
Procter & Gamble downgraded to Hold at Argus on limited organic growth recovery
As reported earlier, Argus analyst John Staszak downgraded Procter & Gamble to Hold from Buy, saying organic growth has not improved to the expected extent even after the company spun off its Beauty and other businesses in recent years. Staszak adds P&G continues to lose market share to "fierce" competition, while its margin expansion has also slowed. The analyst sees the current valuation multiple of 17.7-times his FY18 EPS view as fair, but adds he would consider a more constructive stance if organic growth accelerated.
OXM Oxford Industries
$88.16

-4.31 (-4.66%)

06/07/18
DADA
06/07/18
NO CHANGE
Target $107
DADA
Buy
Oxford Industries price target raised to $107 from $91 at DA Davidson
DA Davidson analyst Michael Kawamoto raised his price target for Oxford Industries to $107 ahead of the company's Q1 results on June 12. The analyst expects a solid Q1 report with positive commentary for the year. Lilly's increasing brand momentum and easier comps to 2017, and Tommy's improving operations should make 2018 "another productive year," Kawamoto tells investors in a pre-earnings research note. He believes the Q1 guidance is achievable and reiterates a Buy rating on Oxford Industries.
06/13/18
RILY
06/13/18
NO CHANGE
Target $97
RILY
Buy
Oxford Industries price target raised to $97 from $93 at B. Riley FBR
B. Riley FBR analyst Susan Anderson raised her price target for Oxford Industries to $97 saying Q2-to-date trends are showing "strong momentum." The analyst keeps a Buy rating on the shares following the company's Q1 results.
06/13/18
KEYB
06/13/18
NO CHANGE
Target $98
KEYB
Overweight
Oxford Industries price target raised to $98 from $92 at KeyBanc
KeyBanc analyst Edward Yruma raised his price target for Oxford Industries to $98 from $92 after the company posted "solid" results in the Q1 despite some weather impact. The analyst reiterates an Overweight rating on the shares.
04/02/18
RHCO
04/02/18
NO CHANGE
Target $90
RHCO
Buy
Oxford Industries price target lowered to $90 at SunTrust on reduced sales view
SunTrust analyst Pamela Quintiliano lowered her price target on Oxford Industries to $90 from $92 following the company's Q4 earnings and below-consensus outlook for Q1. Quintiliano says that the company's reduced dependence on wholesale channels and higher marketing costs are having a "disproportionate" early 2018 impact, but adds that she remains impressed with its "unique positioning, focus on brand preservation and future growth prospects with existing brands". The analyst keeps her Buy rating on Oxford Industries.

TODAY'S FREE FLY STORIES

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

, POL

PolyOne

$30.74

-0.24 (-0.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cooper-Standard licenses Fortrex material platform to PolyOne Corp. »

Cooper Standard (CPS) has…

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

POL

PolyOne

$30.74

-0.24 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.20

0.08 (3.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cellectar Biosciences granted Japanese patent for CLR 131 »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$1.35

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Conference/Events
Viveve Medical to hold a webinar »

Webinar entitled,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TRPX

Therapix Biosciences

$5.33

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Hot Stocks
Therapix Biosciences provided update regarding LOI with FSD »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESQ

Esquire Financial

$24.00

0.27 (1.14%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Hot Stocks
Esquire Financial names Eric Bader as COO, Michael Lacapria as CFO »

Esquire Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$14.61

-1.28 (-8.06%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Downgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

WELL

Welltower

$73.07

-0.66 (-0.90%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Upgrade
Welltower rating change  »

Welltower upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

, VSAT

ViaSat

$65.44

-0.01 (-0.02%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Conference/Events
Morgan Stanley to hold a summit »

Space Summit to be held…

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

VSAT

ViaSat

$65.44

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

ONCS

OncoSec

$0.87

0.0553 (6.79%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Hot Stocks
OncoSec announces new data on treatment with TAVO »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Jefferies to hold a summit »

Office & Industrial…

PWR

Quanta Services

$30.72

-0.6 (-1.92%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Quanta Services management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AGYS

Agilysys

$15.51

-0.08 (-0.51%)

, ALRM

Alarm.com

$49.99

-0.7 (-1.38%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Maxim to hold a conference »

Maxim Group TMT…

AGYS

Agilysys

$15.51

-0.08 (-0.51%)

ALRM

Alarm.com

$49.99

-0.7 (-1.38%)

ATNI

ATN International

$76.15

-1.62 (-2.08%)

BRQS

Borqs Technologies

$3.88

-0.02 (-0.51%)

CTRL

Control4

$20.01

0.24 (1.21%)

EBIX

Ebix

$47.91

0.74 (1.57%)

HYRE

HyreCar

$2.14

0.36 (20.22%)

MCLD

McLeodUSA

$0.00

(0.00%)

OSTK

Overstock.com

$18.89

1.52 (8.75%)

SMCI

Super Micro Computer

$0.00

(0.00%)

STMP

Stamps.com

$172.88

1.12 (0.65%)

TEUM

Pareteum

$1.69

-0.02 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

UBER

Uber

$0.00

(0.00%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Periodicals
Uber seeks to expand relationship with Transport for London, FT reports »

Uber has had discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCLR

Oclaro

$8.27

(0.00%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Options
One option delisting on December 11th »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

$13.73

0.16 (1.18%)

08:30
12/11/18
12/11
08:30
12/11/18
08:30
Conference/Events
Primo Water management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HT

Hersha Hospitality

$18.49

-0.27 (-1.44%)

08:28
12/11/18
12/11
08:28
12/11/18
08:28
Downgrade
Hersha Hospitality rating change  »

Hersha Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$55.95

-2.45 (-4.20%)

08:27
12/11/18
12/11
08:27
12/11/18
08:27
Periodicals
Chinese consumers boycott Canada Goose over Huawei, Globes Times reports »

Canada Goose is a target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBX

Unity Biotechnology

$14.27

0.27 (1.93%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Conference/Events
Unity Biotechnology to hold an event on cellular senescence »

Experts discuss the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BCO

Brink's

$61.97

-0.13 (-0.21%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Hot Stocks
Brink's enters $50M accelerates share repurchase »

Brink's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Downgrade
CalAmp rating change  »

CalAmp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

DVMT

Dell Technologies

$104.13

0.12 (0.12%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Dell Technologies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Mar

AWK

American Water

$97.50

-0.22 (-0.23%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
American Water to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENB

Enbridge

$31.40

-0.54 (-1.69%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Enbridge to hold investor conference »

2018 Enbridge Day--Annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CNNE

Cannae Holdings

$17.00

0.26 (1.55%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Cannae Holdings participates in a conference call with Stephens »

President Bickett and EVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

ACRX

AcelRx

$3.34

-0.03 (-0.89%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
AcelRx to hold an analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.